Copyright
©The Author(s) 2003.
World J Gastroenterol. Sep 15, 2003; 9(9): 1995-1998
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.1995
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.1995
Figure 3 Inhibition of expression of mRNA of LS174T cell by docetaxel.
After treated with 0.1, 0.2, 0.5, 1.0 ng/mL concen-tration of docetaxel, the level of VEGF, bFGF, MMP2, MMP9 protein of LS174T cell was inhibited by docetaxel respectively. Representative results from three independent experiments. a. b. c. d. e. VEGF, bFGF, MMP2, MMP9 mRNA and GAPDH (210 bp, 734 bp, 426 bp, 659 bp and 310 bp, 500 bp). Con: docetaxel solvent control group, a. b. c. d; 1-3: 0.1, 0.5, 1.0 ng/mL concentrations of docetaxel. M: marker, e; 1-4: Internal control groups.
- Citation: Guo XL, Lin GJ, Zhao H, Gao Y, Qian LP, Xu SR, Fu LN, Xu Q, Wang JJ. Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. World J Gastroenterol 2003; 9(9): 1995-1998
- URL: https://www.wjgnet.com/1007-9327/full/v9/i9/1995.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i9.1995